title: [Locally recurring extramedullary plasmacytoma of the upper aerodigestive tract].
abstract: BACKGROUND
  Extramedullary plasmacytomas (EMP) are plasma cell tumors in which by definition the primary tumor is extramedullary. Most of them are found in the upper aerodigestive tract.
  
  
  METHODS
  In this study we describe 3 patients with EMP. The first case is a locally recurrent EMP with recurrent involvement of cervical lymph nodes. The first manifestation of EMP was 31 years ago. Hence, this is one of the longest clinical courses of recurrent EMP ever described in the literature. Case 2 is a locally aggressive recurrent EMP. Case 3 is a localized solitary EMP that could be successfully treated by surgery alone.
  
  
  CONCLUSIONS
  Different classifications of EMP described in the literature are discussed. If these classifications are applied to our cases neither the tumor stage nor the histological picture allow definite conclusions about the prognoses to be drawn. Metastases in regional lymph nodes do not necessarily mean a worse prognosis. Overall, compared to MM with a ten year survival rate of 18% the prognosis is more favorable in EMP with a ten year survival rate of 50%. After a generalized plasma cell neoplasia has been excluded EMP in the head and neck should be treated like a locally aggressive and potentially metastatic tumor. From our experiences we recommend a primary surgical therapy followed by radiation therapy if necessary.
authors.affiliation: Universitäts-HNO-Klinik Tübingen. ingo.baumann@t-online.de
authors.forename: I
authors.initials: I
authors.lastname: Baumann
authors.forename: P
authors.initials: P
authors.lastname: Ruck
authors.forename: F
authors.initials: F
authors.lastname: Dammann
authors.forename: P K
authors.initials: PK
authors.lastname: Plinkert
mesh_terms: D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009296:Nasal Cavity / Q000473:pathology; D009303:Nasopharyngeal Neoplasms / Q000473:pathology* / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D009669:Nose Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D010157:Palatal Neoplasms / Q000473:pathology* / Q000601:surgery; D010160:Palate, Soft / Q000473:pathology; D010954:Plasmacytoma / Q000145:classification / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D011879:Radiotherapy Dosage; D013997:Time Factors; D014057:Tomography, X-Ray Computed